Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)
ConditionDiabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2+
SponsorDexCom, Inc.
About this trial
"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"
Eligibility criteria
Qualifiers
Meets Dexcom CGM System Indications for Use (IFU) per approved commercial labeling
Has at least one HbA1C (Hemoglobin a1c) measurement within three (3) months prior to the Dexcom CGM System use start date that is at least three (3) months after any prior CGM use
Subject is willing and able to use Dexcom CGM System according to approved product labeling
Subject is willing and able to complete applicable patient reported outcome assessments/ surveys
Disqualifiers
Is contraindicated for a Dexcom CGM System per approved commercial labeling
In the Investigator's opinion, the subject is not considered to be a suitable candidate
Trial design
Treatments tested in this trial
- Dexcom CGM G6/G6 Pro/G7
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov